InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 27, 2025

Primary Completion Date

August 30, 2025

Study Completion Date

August 30, 2025

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

InsuLearn

InsuLearn is an artificial intelligence (AI)-algorithm that analyses collected participants data: CGM, insulin, and meal categories to learn the optimal insulin dose. InsuLearn will run offline in a study laptop to generate the optimal insulin dose for each meal category. The algorithm will generate an ambulatory glucose profile (AGP) report with new settings for the InPen™ meal estimation bolus calculator. The study physician will review the report and the algorithm recommendations. The study physician can accept or modify the algorithm recommendations as per his judgment. The new settings will be used during the intervention admission.

Trial Locations (1)

22903-2981

RECRUITING

University of Virginia Center for Diabetes Technology, Charlottesville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

University of Virginia

OTHER

NCT06411548 - InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy | Biotech Hunter | Biotech Hunter